Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Cantor Fitzgerald
Citi
Moodys
Fish and Richardson
Colorcon
Deloitte
Chinese Patent Office
Queensland Health

Generated: May 21, 2018

DrugPatentWatch Database Preview

Emcure Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for EMCURE PHARMS, and what generic and branded alternatives to EMCURE PHARMS drugs are available?

EMCURE PHARMS has twenty-seven approved drugs.

There are three tentative approvals on EMCURE PHARMS drugs.

Summary for Emcure Pharms
US Patents:0
Tradenames:24
Ingredients:23
NDAs:27

Drugs and US Patents for Emcure Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emcure Pharms Ltd ACARBOSE acarbose TABLET;ORAL 202271-002 Feb 7, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Emcure Pharms Ltd ADENOSINE adenosine SOLUTION;IV (INFUSION) 202313-001 Sep 15, 2014 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Emcure Pharms Ltd AMIKACIN SULFATE amikacin sulfate INJECTABLE;INJECTION 204040-001 Dec 12, 2013 AP RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial
Emcure Pharms Ltd LEVOFLOXACIN levofloxacin INJECTABLE;INJECTION 202590-002 Jan 24, 2013 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Federal Trade Commission
Julphar
Teva
Baxter
Fish and Richardson
UBS
Farmers Insurance
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.